Kim Byung-Jang – CEO, Mega Medical – South Korea
The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global…
Since its establishment in 1995, Mega medical Co., Ltd. has localized medical equipment for ear-note-and throat (ENT), and currently been ranked No. 1 in domestic market share. This company will make every effort not only to maintain No. 1 market share in domestic market but also to take the first position in overseas markets.
1997 Specialized ENT unit launch
1999 Patent acquisition for wall-type nebulizer
2005 Cell-Q, a new obesity treatment product development
2006 Wireless visual system is selected as (wireless visual system) the world best quality product
2007 Digital wireless visual system development
2008 Obesity treatment device solution, Nato irrigation development
2009 HD visual system Development
2010 technical development for ENT Microscope development
2011 LIPO carbon therapy development
2013 Obesity treatment complex device development
Through consistent overseas market development since the establishment, Mega medical Co., Ltd. have exported out products over 40 countries including Europe, Asia, China, and Middle-East, and worked for global network construction.
Contact Details
Domestic inquiries
domestic@megamedical.co.kr
Tel. 1588-4493 (02-3662-4493)
Fax. 02-3661-0120
For overseas clients
Inquiry about products and warranty
webmaster@megamedical.co.kr
Tel. +82-2-3662-4493
Fax. +82-2-3661-0120
Address
#2504, 2505, A Bldg, Woolim blue 9 Business Center, 583, Yangcheon-ro, Gangseo-gu, Seoul (ZIP 157-779)
The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global…
A Korean research team at Ulsan National Institute of Science and Technology (UNIST) have developed a cunning technology for treatments that attack cancer cells. Treatments that travel through the…
From Wednesday 31st October to Friday 2nd November, Seoul hosted the KoNECT-MFDS International conference, promoting South Korea’s clinical research capabilities on a global platform. The fourth of its kind, the…
Celltrion Healthcare, the marketing arm of the biopharmaceutical company Celltrion won a huge deal in France last Friday (2nd November 2018) with big tenders for Herzuma, a biosimilar of Roche’s…
Korea is fast becoming a big player in the pharmaceutical industry, especially within the biotech arena. With 4% of the total pipelines in the world, the country is showing strong…
Korean Pharma company, Hanmi has won orphan drug status this week from the US Food and Drug Administration (FDA) for HM43239, a drug for the treatment of acute myeloid leukaemia…
Local flagship company Boryung has found success with its newly developed angiotension receptor blocker (ARB) Kanarb. Nine molecules currently exist worldwide in this category of antihypertensives, and Kanarb is currently…
The growth of clinical trials in Korea has been remarkable in recent years. The number of clinical trials performed by multinationals has shot up from five in 2000 to 303…
Korea’s economy has been dominated for decades by chaebols, large family-owned business conglomerates like Samsung, Hyundai, and LG, known for their hierarchical structures and success in Korea’s traditional sectors. However,…
Medytox is the most valuable pharmaceutical business in Korea, with a highly successful botulinum toxin product on the market, and can only grow further when they finish development of their…
“When I left Janssen, I never imagined joining a Korean company,” recalls Choi Tae-Hung, sipping a freshly brewed yujacha tea in his office on a crisp autumn morning as he…
Minister Moon discusses the results of his recent state visit to the Middle East with Korea’s President, and Korea’s assets and potential as a global healthcare partner in developing and…
The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global…
See our Cookie Privacy Policy Here
